DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Information source: Novo Nordisk A/S
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Growth Hormone Disorder; Adult Growth Hormone Deficiency

Intervention: somatropin (Drug)

Phase: N/A

Status: Completed

Sponsored by: Novo Nordisk A/S

Official(s) and/or principal investigator(s):
Global Clinical Registry (GCR, 1452), Study Director, Affiliation: Novo Nordisk A/S

Summary

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin« long-term treatment of growth hormone deficiency in adults.

Clinical Details

Official title: A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate the Long-term Safety and Efficacy of Norditropin« Formulation in Patients With AGHD

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Number and type of suspected serious adverse drug reactions (SADRs) during the study period

Secondary outcome:

Number of impaired glucose tolerance events during the study period

Number of other types of adverse events (AEs) during the study period

Effects on body composition (body fat percentage, lean body weight mass, bone density, bone mineral density)

Effects of insulin-like growth factor-1 (IGF-I) levels

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Severe adult growth hormone deficiency

Exclusion Criteria:

- Known or suspected allergy to study product(s) or related products

- Previous participation in the study

- Diabetes Mellitus

- Presence of malignant tumor(s)

- Pregnant or likely to get pregnant

Locations and Contacts

Tokyo 1000005, Japan
Additional Information

Clinical Trials at Novo Nordisk

Starting date: October 2009
Last updated: January 7, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017